Compagnie Des Levures Lesaffre SA launched a mandatory offer to acquire remaining 23% stake in NattoPharma ASA (OB:NATTO) for approximately NOK 170 million on April 19, 2021. Under the terms of transaction,Compagnie Des Levures Lesaffre will acquire shares at an offer per share of NOK 35 in cash . On 19 April 2021 Transaction has been approved by Oslo Børs, in capacity as take-over supervisory authority. The Offer Document, containing the full terms and conditions of the Offer will, subject to regulatory restrictions in certain jurisdictions, be sent today, 20 April 2021, to all shareholders in NattoPharma whose address appears in NattoPharma's share register in the Norwegian Central Securities Depositary. Offer period is from 20 April 2021 to 18 May 2020, subject to extension for a maximum period of 2 weeks. On May 18, 2021, the Offeror owns or has received acceptances for a total of 20,622,305 shares, representing in total 98.03% (excluding treasury shares) of the share capital of NattoPharma). Given that the Offeror now holds more than 90% of the share capital of NattoPharma, a compulsory acquisition (a squeeze out) of the remaining shares not owned by the Offeror and a delisting will be carried out in due course.